THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2
Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection. L'invention concerne des...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said antibodies or fragments thereof for preventing or treating, for example a coronavirus infection.
L'invention concerne des anticorps ou des fragments de ceux-ci ayant une spécificité vis-à-vis d'une protéine de spicule de sarbecovirus. L'invention concerne également des compositions, des méthodes et des kits pour utiliser lesdits anticorps ou fragments de ceux-ci afin de prévenir ou traiter, par exemple, une infection à coronavirus. |
---|